Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q2 2021 vs. Q1 2021
How the institutions holding Mesoblast Ltd changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 52 | 50 | −2 |
| Shares | 2.67M | 3.95M | +1.28M (+47.9%) |
| Value | $21.9M | $28.9M | +$7.03M (+32.2%) |
New holders (8)
Institutions that held Mesoblast Ltd at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 90,000 | $673.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 26,640 | $199.0K | 0.00% |
| Group One Trading, L.P. | 22,038 | $165.0K | 0.00% |
| Advisor Resource Council | 10,000 | $75.0K | 0.01% |
| Moors & Cabot, Inc. | 45,131 | $67.0K | 0.00% |
| Brewin Dolphin Ltd | 5,900 | $44.1K | 0.00% |
| Eaton Vance Management | 100 | $1.00K | 0.00% |
| Financial Management Professionals, Inc. | 57 | $0 | 0.00% |
Sold out (10)
Institutions that held Mesoblast Ltd at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Jane Street Group, LLC | 23,568 | $194.0K |
| Squarepoint Ops LLC | 14,818 | $123.0K |
| Wells Fargo & Company | 9,680 | $80.0K |
| Bank of Montreal | 5,105 | $44.0K |
| Steward Partners Investment Advisory, LLC | 4,200 | $34.7K |
| International Assets Investment Management, LLC | 3,000 | $25.0K |
| Sowell Financial Services LLC | 1,058 | $7.00K |
| NEXT Financial Group, Inc | 500 | $4.00K |
| WealthShield Partners, LLC | 500 | $4.00K |
| RMR Wealth Builders | 150 | $1.00K |